The landscape of clinical research is undergoing a seismic shift. In Riyadh, the heart of Saudi Arabia’s medical innovation, the transition from site-centric models to Decentralized Clinical Trials (DCT) is no longer a luxury—it is a strategic imperative driven by Saudi Vision 2030. As a leading factory and supplier, we recognize that Remote Patient Monitoring (RPM) is the backbone of this transformation.
Our solutions provide Information Gain by integrating environmental sensor data with physiological metrics, allowing researchers in Riyadh to understand how local climate conditions impact drug efficacy and patient health in real-time. This level of granular detail is what differentiates a standard supplier from a strategic growth partner.
Our macro-industry solutions bridge the gap between traditional clinical sites and the patient's home. In Riyadh’s expanding urban landscape, traveling to a central hospital for weekly check-ups can be a deterrent for study participants. Our RPM suite enables:
Operating in the Riyadh market requires more than just high-tech hardware; it requires deep expertise in the local regulatory framework. We provide comprehensive support to ensure your clinical trial meets every benchmark set by the Saudi Food and Drug Authority (SFDA) and the National Committee of BioEthics (NCBE).
All user interfaces (UI) and patient instructions are professionally translated into Arabic, respecting local dialects to ensure high adherence among Saudi participants.
Our cloud infrastructure is compatible with local providers like STC Cloud and Zain, ensuring that sensitive patient health information (PHI) never leaves the Kingdom.
Devices are tested for Riyadh's specific environmental conditions, ensuring sensors remain accurate in temperatures up to 50°C and high-dust environments.
As a forward-thinking factory, we are not just building for today; we are architecting the future of healthcare in Riyadh. Our R&D roadmap includes:
By enabling real-time data collection, researchers can perform "interim analysis" more frequently, potentially shortening trial durations by 3-6 months. It also removes geographical barriers, allowing patients from Jeddah or Dammam to participate in Riyadh-led trials without travel.
Yes, all our clinical trial monitoring devices undergo rigorous international certification (CE, FCC, RoHS) and we provide the necessary documentation to support your SFDA registration process in the Kingdom.
Absolutely. As a factory with OEM/ODM capabilities, we can customize sensors for oncology, cardiology, respiratory studies, and more, specifically tailored to the protocol requirements of your CRO.
We offer a localized support model, including 24/7 technical assistance and device replacement services through our Riyadh-based logistics partners.
Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016, the company is located in Dongguan, China, a major center for advanced manufacturing, medical technology development, and electronic innovation.
Operating from a modern facility covering more than 11,000 square meters, with a team of over 230 employees, Trial Medical is dedicated to developing and manufacturing innovative technologies that support clinical research organizations, pharmaceutical companies, healthcare institutions, and academic research centers worldwide.
The company's product portfolio includes remote clinical trial monitoring devices, wearable health data collection systems, patient engagement platforms, electronic clinical outcome assessment solutions, digital research tools, remote safety monitoring systems, and decentralized trial support technologies. Supported by an experienced team of engineers, software developers, and quality management professionals, Trial Medical continuously invests in research and development to address the evolving needs of modern clinical studies.
Trial Medical
